跳至主要内容
临床试验/ISRCTN15088122
ISRCTN15088122已完成未知

Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial

ondon School of Hygiene and Tropical Medicine (UK)0 个研究点目标入组 12,737 人开始时间: 2011年7月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12,737

研究概览

简要总结

2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/22721545 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31623894 (added 21/10/2019) 2020 sub-study results in https://pubmed.ncbi.nlm.nih.gov/33262252/ (added 07/12/2020) 2021 results in https://pubmed.ncbi.nlm.nih.gov/33928903/ (added 05/05/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 2. Traumatic brain injury
  • 3. Within 8 hours of injury (Added 22/01/18: limited to within 3 hours from September 2016)
  • 4. Any intracranial bleeding on CT scan OR a GCS of 12 or less
  • 5. No significant extra-cranial haemorrhage
  • 6. Where the responsible clinician is substantially uncertain as to the appropriateness of antifibrinolytic agents in the patient

排除标准

  • The fundamental eligibility criterion is the responsible clinician's 'uncertainty' as to whether or not to use an antifibrinolytic agent in a particular patient with traumatic brain injury

研究者

发起方
ondon School of Hygiene and Tropical Medicine (UK)

相似试验